Key result
Impaired renal function is linked to nearly 3-fold higher 30-day MACE risk in chest pain.
Why the study?
Previous studies demonstrated increased risk of acute coronary syndrome among patients with chest pain and renal dysfunction, but the impact of renal dysfunction on cardiac outcomes in emergency department observation unit patients was unclear.
Cohort (n=1,067)
Answers are grounded in this paper and cite their sources.
Renal dysfunction may signal higher MACE risk in EDOU chest pain patients; extends observational data but leaves practice change open pending trials.
OBJECTIVES: Previous studies have demonstrated increased risk of acute coronary syndrome among patients with chest pain and renal dysfunction. The objective of this study was to investigate the impact of renal dysfunction on cardiac outcomes in patients with chest pain in an emergency department observation unit (EDOU). METHODS: We conducted a 5-year prospective evaluation of patients evaluated in the EDOU for chest pain. We collected baseline information and data from the emergency department visit, EDOU stay, inpatient admission, and the 30-day period after presentation to the emergency department. We calculated glomerular filtration rate (GFR) using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. We stratified patients as having mild (GFR 60-89 mL/min per 1.73 m) or at least moderate (GFR <60) renal dysfunction. We evaluated the rate of major adverse cardiac events (MACE: myocardial infarction, stent, coronary artery bypass graft, and death). RESULTS: Of 1067 enrolled EDOU patients, the majority had at least mild renal dysfunction: 39% [95% confidence interval (95% CI): 36.1%-42%] had a GFR between 60 and 89, and 16% (95% CI: 14%-18.4%) had a GFR <60. MACE rates increased with decreasing GFR: 3.3% (95% CI: 2.1%-5.3%) for GFR ≥90, 7.3% (95% CI: 5.2%-10.2%) for GFR 60-89, and 9.1% (95% CI: 5.7%-14.3%) for GFR <60 (P = 0.005). In multivariate analysis, patients with at least mild renal dysfunction (GFR < 90) were at greater risk of MACE (P = 0.028). CONCLUSIONS: We noted a high prevalence of renal dysfunction among EDOU patients evaluated for chest pain. Even those with mild renal dysfunction demonstrated an increased risk of MACE. Clinicians may wish to consider renal dysfunction in selecting appropriate patients for EDOU placement.
No takes yet. Share an insight, caveat, or question.
Carlberg et al. (2019) conducted a cohort in Chest pain (n=1,067). Renal dysfunction (GFR <90) vs. Normal renal function (GFR ≥90) was evaluated on Major adverse cardiac events (MACE: myocardial infarction, stent, coronary artery bypass graft, and death) (p=0.005). Decreased renal function was associated with higher 30-day MACE risk among emergency department observation patients with chest pain (3.3% for GFR ≥90, 7.3% for GFR 60-89, 9.1% for GFR <60; P=0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: